Investitionsbank des Landes Brandenburg

HelloBetter is a pioneering company in the field of digital therapeutics for mental health, founded in 2015 as a university spin-off by renowned research psychologists. Headquartered in Hamburg, Germany, with an additional office in Berlin, HelloBetter offers a range of online psychological training programs aimed at managing conditions such as stress, depression, anxiety, panic disorders, and sleep disturbances. The company's innovative approach has led to the approval of six of its online therapy programs as prescription digital therapeutics under the German DiGA framework, allowing them to be accessed at no cost by over 73 million people in Germany. With a total of ten digital therapeutics evaluated in numerous randomized controlled trials, HelloBetter is committed to making evidence-based mental health care accessible worldwide. The company is actively expanding its reach beyond the DACH region, supported by a recent funding round.

HelloBetter is a pioneering company in the field of digital therapeutics for mental health, founded in 2015 as a university spin-off by renowned research psychologists. Headquartered in Hamburg, Germany, with an additional office in Berlin, HelloBetter offers a range of online psychological training programs aimed at managing conditions such as stress, depression, anxiety, panic disorders, and sleep disturbances. The company's innovative approach has led to the approval of six of its online therapy programs as prescription digital therapeutics under the German DiGA framework, allowing them to be accessed at no cost by over 73 million people in Germany. With a total of ten digital therapeutics evaluated in numerous randomized controlled trials, HelloBetter is committed to making evidence-based mental health care accessible worldwide. The company is actively expanding its reach beyond the DACH region, supported by a recent funding round.

Dryad Networks GmbH, based in Berlin and Eberswalde, Germany, specializes in innovative fire detection and forest health monitoring solutions aimed at protecting vital ecosystems. Founded in 2020, the company develops a large-scale Internet of Things (IoT) network that allows public and private forest owners to monitor and analyze their woodlands effectively. Dryad's technology integrates sensor nodes, distributed gateways, and a robust analytics platform, enabling early detection of wildfires and safeguarding against various environmental threats. By focusing on the preservation of forests, Dryad Networks contributes to the protection of essential carbon sinks and natural habitats, ensuring their longevity for future generations.

Sensmore specializes in artificial intelligence automation software tailored for heavy machinery, specifically in the mining sector. The company offers a comprehensive asset management platform that integrates proprietary perception software with readily available sensor technology. This technology is designed to be adaptable and cost-effective, allowing mine operators to enhance productivity, reduce operational expenses, and improve safety measures. By focusing on automation solutions, Sensmore aims to transform the efficiency of heavy vehicle operations within the industry.

Noah Labs is a technology company focused on developing software-based medical devices for the early detection of cardiovascular diseases through voice analysis. Their innovative digital health platform leverages voice-based machine learning to monitor patients and identify digital biomarkers, facilitating personalized and predictive virtual care. By utilizing this novel technology, Noah Labs aims to enhance patient outcomes, allowing individuals with cardiovascular conditions to lead healthier and longer lives from the comfort of their homes.

Dryad Networks GmbH, based in Berlin and Eberswalde, Germany, specializes in innovative fire detection and forest health monitoring solutions aimed at protecting vital ecosystems. Founded in 2020, the company develops a large-scale Internet of Things (IoT) network that allows public and private forest owners to monitor and analyze their woodlands effectively. Dryad's technology integrates sensor nodes, distributed gateways, and a robust analytics platform, enabling early detection of wildfires and safeguarding against various environmental threats. By focusing on the preservation of forests, Dryad Networks contributes to the protection of essential carbon sinks and natural habitats, ensuring their longevity for future generations.

GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.

SageWealth provides a range of investing options focusing on sustainability, including growth-focused equity-based and safety-focused bond and commodity-based options.

Dryad Networks GmbH, based in Berlin and Eberswalde, Germany, specializes in innovative fire detection and forest health monitoring solutions aimed at protecting vital ecosystems. Founded in 2020, the company develops a large-scale Internet of Things (IoT) network that allows public and private forest owners to monitor and analyze their woodlands effectively. Dryad's technology integrates sensor nodes, distributed gateways, and a robust analytics platform, enabling early detection of wildfires and safeguarding against various environmental threats. By focusing on the preservation of forests, Dryad Networks contributes to the protection of essential carbon sinks and natural habitats, ensuring their longevity for future generations.

ScaleHub is a managed service hub specializing in AI data labeling and processing, focusing on delivering high-quality data at scale. The company operates a crowdsourcing platform that modernizes traditional data extraction and document processing by leveraging artificial intelligence. This platform connects users to both public and private crowds globally, as well as a virtual workforce, enhancing document automation capabilities. ScaleHub's services are designed to support shared service centers and business process outsourcers, allowing them to scale their operations as needed. The company's solutions are compliant with regulations such as HIPAA, ISO 27001:2013, and GDPR, ensuring data security and integrity.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in developing smartphone microscopes integrated with innovative image recognition technology. The company leverages artificial intelligence to automate manual image analysis, significantly enhancing laboratory efficiency. Its flagship products, the Oculyze BB 2.0 and Oculyze FW yeast cell counter apps, enable breweries and wineries to conduct real-time quantitative analysis of yeast cells through a smartphone-connected microscope. This process replaces traditional methods, such as using a haemocytometer, with a faster and more reliable solution for monitoring fermentation. Oculyze continues to expand its cloud-based image recognition platform to include applications in various fields, such as ethanol production, medical diagnostics, and environmental analysis. Additionally, the company offers turnkey solutions that integrate image analysis and recognition software with existing systems, ensuring flexibility and improved performance for its clients.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in developing smartphone microscopes integrated with innovative image recognition technology. The company leverages artificial intelligence to automate manual image analysis, significantly enhancing laboratory efficiency. Its flagship products, the Oculyze BB 2.0 and Oculyze FW yeast cell counter apps, enable breweries and wineries to conduct real-time quantitative analysis of yeast cells through a smartphone-connected microscope. This process replaces traditional methods, such as using a haemocytometer, with a faster and more reliable solution for monitoring fermentation. Oculyze continues to expand its cloud-based image recognition platform to include applications in various fields, such as ethanol production, medical diagnostics, and environmental analysis. Additionally, the company offers turnkey solutions that integrate image analysis and recognition software with existing systems, ensuring flexibility and improved performance for its clients.

ODE.Systems provides users, a fun and sustainable decision and evaluation tool. Ode.systems provides a state of the art combination of a convenient and fun system including comprehensive scientific based knowledge and collected data to ease the process. Shared processes resulting in better decisions followed by elevated conscious decision making process. Social Impact Start-up Elevator Pitch https://youtu.be/OjDyxoXA1Oc, 60 sec.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in developing smartphone microscopes integrated with innovative image recognition technology. The company leverages artificial intelligence to automate manual image analysis, significantly enhancing laboratory efficiency. Its flagship products, the Oculyze BB 2.0 and Oculyze FW yeast cell counter apps, enable breweries and wineries to conduct real-time quantitative analysis of yeast cells through a smartphone-connected microscope. This process replaces traditional methods, such as using a haemocytometer, with a faster and more reliable solution for monitoring fermentation. Oculyze continues to expand its cloud-based image recognition platform to include applications in various fields, such as ethanol production, medical diagnostics, and environmental analysis. Additionally, the company offers turnkey solutions that integrate image analysis and recognition software with existing systems, ensuring flexibility and improved performance for its clients.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in developing smartphone microscopes integrated with innovative image recognition technology. The company leverages artificial intelligence to automate manual image analysis, significantly enhancing laboratory efficiency. Its flagship products, the Oculyze BB 2.0 and Oculyze FW yeast cell counter apps, enable breweries and wineries to conduct real-time quantitative analysis of yeast cells through a smartphone-connected microscope. This process replaces traditional methods, such as using a haemocytometer, with a faster and more reliable solution for monitoring fermentation. Oculyze continues to expand its cloud-based image recognition platform to include applications in various fields, such as ethanol production, medical diagnostics, and environmental analysis. Additionally, the company offers turnkey solutions that integrate image analysis and recognition software with existing systems, ensuring flexibility and improved performance for its clients.

Emoree is a mobile reading platform that aims to enhance reading and language skills for users of all ages. Established in 2016 and located on the Campus of TH Wildau near Berlin, Germany, the platform provides a cloud-based educational resource that enables learners to improve their reading speed, comprehension, and retention. Emoree's offerings include personalized exercises of varying difficulty levels, supported by continuous reading diagnostics. This adaptive approach allows users to tailor their learning experience according to their individual needs across all subjects and educational levels.

ScaleHub is a managed service hub specializing in AI data labeling and processing, focusing on delivering high-quality data at scale. The company operates a crowdsourcing platform that modernizes traditional data extraction and document processing by leveraging artificial intelligence. This platform connects users to both public and private crowds globally, as well as a virtual workforce, enhancing document automation capabilities. ScaleHub's services are designed to support shared service centers and business process outsourcers, allowing them to scale their operations as needed. The company's solutions are compliant with regulations such as HIPAA, ISO 27001:2013, and GDPR, ensuring data security and integrity.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in developing smartphone microscopes integrated with innovative image recognition technology. The company leverages artificial intelligence to automate manual image analysis, significantly enhancing laboratory efficiency. Its flagship products, the Oculyze BB 2.0 and Oculyze FW yeast cell counter apps, enable breweries and wineries to conduct real-time quantitative analysis of yeast cells through a smartphone-connected microscope. This process replaces traditional methods, such as using a haemocytometer, with a faster and more reliable solution for monitoring fermentation. Oculyze continues to expand its cloud-based image recognition platform to include applications in various fields, such as ethanol production, medical diagnostics, and environmental analysis. Additionally, the company offers turnkey solutions that integrate image analysis and recognition software with existing systems, ensuring flexibility and improved performance for its clients.

Until now, online shops haven't been able to offer the level of personalized fashion advice available in brick-and-mortar stores. Inspora brings fashion guidance to every online shop, with a digital shopping assistant that automatically leads each individual customer through the shopping process - from finding the right style to searching for outfits and products to checking out. The result: satisfied customers and more sales for online shops. Brands and retailers can integrate Inspora into their online shop as a chat widget, tailored exclusively to their functional requirements, product range and branding. Inspora is the first solution developed specifically for the fashion industry, using artificial intelligence and chatbot technology, that draws on the digitalized knowledge of hundreds of human personal stylists, allowing fully automatic fashion advice to be offered for the first time. The German Federal Ministry for Economic Affairs awarded Inspora with the EXIST Business Start-up Grant for its innovative technology. - Tagesspiegel: "What on earth am I going to wear? Inspora provides fashion-conscious women with the answer to this question with the help of artificial intelligence.” - Berliner Zeitung: “Chatting with Inspora is fun and a useful source of inspiration for women of all ages.“ - Handelsblatt: "It took six months to develop the algorithm, which drew on the experience of over 100 human stylists."​ - The Federal Government: "Inspora is in fact a machine. Nevertheless, it is a likeable fashion fanatic and personal assistant – thanks to artificial intelligence (AI)."​

Emperra E-Health Technologies is a German company based in Potsdam, established in 2008, that specializes in the development of telemedical products aimed at managing diabetes. The company focuses on creating GSM and web-based systems for tracking, monitoring, and transmitting crucial diagnostic and therapeutic data related to diabetes. Its innovative diabetes monitoring solutions include a Bluetooth-enabled insulin pen and a wireless blood glucose meter, which allow healthcare professionals to effectively monitor insulin doses, blood sugar levels, and carbohydrate intake in patients. By facilitating real-time data transmission, Emperra enhances the ability of doctors and nurses to manage diabetes care efficiently.

Wirkaufens is a privately held company that sell used cell phones and electronics online.

Clipnow creates virtual 360° real estate rounds as well as spoken, automated videos for website and portals.

EBS Technologies is a medical device company that has developed a stimulation system for the treatment of neurologically caused impairments such as visual field loss. Such impairments can be the result of stroke, traumatic-brain-injury, glaucoma or several other diseases. The EBS Therapy (previously: NEXT WAVE™Therapy) is a non-invasive optic nerve stimulation deploying weak electrical currents, resulting in neuroregeneration and neuroprotection. Low-voltage electrical pulses are administered at frequencies and amplitudes identified as optimal for each patient, allowing retinal ganglion cells to regenerate and branch out new axons. The company benefits from more than 15 years of research and clinical experience with more than 1,200 patients. Double blind, randomized studies, as well as clinical observations show that the EBS Therapy can partially restore vision field in patients. In 2013 EBS Technologies received the CE Mark for the stimulation device and started the commercial treatment in 2014. There are currently 8 EBS Treatment centers across Germany and the company is slowly widening the network.